Treatment of sexual dysfunction with 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2(1H-)-quinolone or salt thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20070142395A1
SERIAL NO

11305277

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Therapeutic methods are provided for treating sexual dysfunction by administration of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2(1H-)-quinolone, or a prodrug or salt thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VELA PHARMACEUTICALS INC820 BEAR TAVERN ROAD SUITE 300 EWING NJ 08628-1021
OTSUKA PHARMACEUTICAL CO LTDTOKYO

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Calcagno, Jeff Hopewell, NJ 4 43
Kucharik, Robert F Glenmoore, PA 22 112
Leventer, Steven M Langhorne, PA 11 49

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation